Different doses or strenghts? [General Sta­tis­tics]

posted by kumarnaidu – Mumbai, India, 2013-11-22 06:34 (3671 d 11:21 ago) – Posting: # 11940
Views: 7,558

Dear Dr_Dan,
Thanks for your prompt reply.

❝ I guess in your case we are talking about comparative bioavailabilities and the test products are no pure generic formulations, right?

Yes you are right here we are talking about comparative bioavailability and the generic they have prepared with slight modifications. But in protocol they are not talking about bioavailability. They will use cohort 1 for identifying dose equiavlent to Reference and using that dose they will show bioequivalence in Cohort 2.

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
22,824 posts in 4,786 threads, 1,633 registered users;
34 visitors (0 registered, 34 guests [including 5 identified bots]).
Forum time: 17:55 CET (Europe/Vienna)

In these matters the only certainty is
that nothing is certain.    Pliny the Elder

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5